Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year
Helen E. Heslop, Edward A. Stadtmauer, John E. Levine, Karen K. Ballen, Yi‐Bin Chen, Amy E. DeZern, Mary Eapen, Mehdi Hamadani, Betty K. Hamilton, Parameswaran Hari, Richard J. Jones, Brent R. Logan, Leslie S. Kean, Eric Leifer, Frederick L. Locke, Richard T. Maziarz, Eneida R. Nemecek, Marcelo C. Pasquini, Rachel Phelan, Marcie Riches, Bronwen E. Shaw, Mark C. Walters, Amy Foley, Steven M. Devine, Mary M. Horowitz
Abstract
In 2021 the BMT CTN held the 4th State of the Science Symposium where the deliberations of 11 committees concerning major topics pertinent to a particular disease, modality, or complication of transplant, as well as two committees to consider clinical trial design and inclusion, diversity, and access as cross-cutting themes were reviewed. This article summarizes the individual committee reports and their recommendations on the highest priority questions in hematopoietic stem cell transplant and cell therapy to address in multicenter trials.